NCT02067975View on ClinicalTrials.gov

Tryptophan MRI in People With Schizophrenia and Healthy Controls

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

August 14, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Schizophrenia
Interventions
DRUG

Tryptophan

DRUG

Placebo

Trial Locations (1)

21228

Maryland Psychiatric Research Center, Catonsville

Sponsors
All Listed Sponsors
collaborator

Mitsubishi Tanabe Pharma Corporation

INDUSTRY

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Maryland, Baltimore

OTHER